TNF and cancer: As TNFR2 exists without DD, it can enhance proliferation and activation of Tregs via 3 main pathways, namely, NF-kB, activator protein 1 (AP1), and MAPK pathways [105], therefore avoiding the immunosuppressive effect of TNF which is similar to cancer cells survival pathways [100].